Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
Post by
Jonathon Brown
on May 08, 2025 9:17am
Buzz on the Bullboards: From oil fields to labs, TSX Stories making waves
Several TSX and TSX Venture-listed companies made significant announcements that could shape their near-term trajectories.
read article.
(24)
•••
SleepyHoward
X
Comment by
SleepyHoward
on May 07, 2025 9:00am
RE:RE:Valuation according to Cohere LLM
Absolutly!
Largest Integrated Facility Services Provider in Canada Releases Financial Results for Q1, 2025
posted May 11, 2025 9:00am by
GDI Integrated Facility Services Inc.
-
|
Adjusted EBITDA* amounted to $34 million, representing an Adjusted EBITDA* margin of 6% compared to $28 million and 4% in Q1 2024. Net income was $6 million or $0.26 per share compared to $0.4 million or $0.02 per share in Q1 2024.Long-term debt, net of cash* decreased by $14 million in the quarter ...read more
(584)
•••
JackPond
X
Comment by
JackPond
on May 07, 2025 8:48am
RE:Valuation according to Cohere LLM
SBM needs actual EARNINGS before we have to start worrying about what the P/E multiple should be. And before that, they need to close the bridge financing, hopefully with insider participation, and
...more
(43)
•••
forhandlaren
X
Post by
forhandlaren
on May 07, 2025 12:55am
Valuation according to Cohere LLM
Question: How many multiples in terms of p/e for a biotech with a premium product on the anti-aging market? Answer: Determining the appropriate price-to-earnings (P/E) multiple for a biotech
...more
(0)
•••
23minus7
X
Comment by
23minus7
on May 07, 2025 12:52am
RE:RE:1326 tidbit and yet another “peptide” competitor
An Analytical Comparison of TFC-1326 and Alastin TriHex Technology: Assessing Claims of Superiority in Advanced Skincare I. Executive Summary This report provides a detailed comparative analysis
...more
(848)
•••
Pandora
X
Comment by
Pandora
on May 06, 2025 9:36pm
RE:1326 tidbit and yet another “peptide” competitor
Would you care to add a "Conclusion" to all of that data or is it just as is, a data set?
(11)
•••
Nitrodouglas
X
Post by
Nitrodouglas
on May 06, 2025 5:36pm
1326 tidbit and yet another “peptide” competitor
1326 Clinical Trial info and yet another “peptide” competitor Compared to the OneSkin information I posted below which is based on Senescence, Sirona’s clinical trial 1 did not test for
...more
(5)
•••
Engcan77
X
Comment by
Engcan77
on May 06, 2025 1:28pm
RE:Iscfa's claim:
I'm not sure why someone would come up with a comment like that at this time when the stock is halted,and the truth will be announced sooner than later. Just bashing management...i guess. I could
...more
(584)
•••
JackPond
X
Post by
JackPond
on May 06, 2025 8:55am
Iscfa's claim:
" SBM is going to give 50% away for a crummy $12M. " We don't know the terms of the deal with Promura, so Iscfa's claim is misleading, at best, an outright intentional lie at the
...more
(848)
•••
Pandora
X
Comment by
Pandora
on May 05, 2025 5:07pm
RE:Trademark
It has taken 15 months to get "Accepted". Will we have another period of time to get it "Approved" or ?? Official status: Application accepted -Status date April 17,
...more
(24)
•••
SleepyHoward
X
Post by
SleepyHoward
on May 05, 2025 12:10pm
Trademark
https://branddb.wipo.int/en/similarname/brand/CA502024002304970
(584)
•••
JackPond
X
Comment by
JackPond
on May 05, 2025 10:42am
RE:Part time CFOs not cutting it
The only material weakness is in your dishonesty.
(1689)
•••
lscfa
X
Post by
lscfa
on May 05, 2025 10:31am
Part time CFOs not cutting it
https://stockhouse.com/companies/bullboard?symbol=v.rht.h&postid=36561376
(848)
•••
Pandora
X
Comment by
Pandora
on May 05, 2025 1:38am
RE:a comparison and fellow competitor
Elizabeth Arden is advertising with Retinol.
(43)
•••
forhandlaren
X
Comment by
forhandlaren
on May 05, 2025 1:27am
RE:a comparison and fellow competitor
Very good read, thanks. One thing that strikes me is that they have a more comprehensive approach compared to SBM. Over the years we have financed all sorts of research, from anti-aging to anti-viral
...more
(11)
•••
Nitrodouglas
X
Post by
Nitrodouglas
on May 04, 2025 9:37pm
a comparison and fellow competitor
A peptide based skincare brand called Oneskin just raised $7million bucks. According to the link, they've raised some 20 million. been in business as a DTC (direct to consumer) for 3 years
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >